RENAU.UNSP.ARD 1/5 EO-20 (56S0) - Total Assets
Based on the latest financial reports, RENAU.UNSP.ARD 1/5 EO-20 (56S0) holds total assets worth €7.92 Billion EUR (≈ $9.26 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
RENAU.UNSP.ARD 1/5 EO-20 - Total Assets Trend (2022–2025)
This chart illustrates how RENAU.UNSP.ARD 1/5 EO-20's total assets have evolved over time, based on quarterly financial data. Also see RENAU.UNSP.ARD 1/5 EO-20 market cap and net worth for the company's overall valuation and market capitalisation.
RENAU.UNSP.ARD 1/5 EO-20 - Asset Composition Analysis
Current Asset Composition (December 2025)
RENAU.UNSP.ARD 1/5 EO-20's total assets of €7.92 Billion consist of 18.1% current assets and 82.0% non-current assets. Review RENAU.UNSP.ARD 1/5 EO-20 balance sheet liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 5.3% |
| Accounts Receivable | €179.80 Million | 2.3% |
| Inventory | €690.90 Million | 8.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.54 Billion | 19.3% |
| Goodwill | €2.88 Billion | 36.1% |
Asset Composition Trend (2022–2025)
This chart illustrates how RENAU.UNSP.ARD 1/5 EO-20's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest RENAU.UNSP.ARD 1/5 EO-20 stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: RENAU.UNSP.ARD 1/5 EO-20's current assets represent 18.1% of total assets in 2025, a decrease from 33.0% in 2022.
- Cash Position: Cash and equivalents constituted 5.3% of total assets in 2025, up from 2.1% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 55.0% of total assets, an increase from 39.0% in 2022.
- Asset Diversification: The largest asset category is goodwill at 36.1% of total assets.
RENAU.UNSP.ARD 1/5 EO-20 Competitors by Total Assets
Key competitors of RENAU.UNSP.ARD 1/5 EO-20 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SARTORIUS (UNSP.ADS)/1/5
F:SRT0
|
Germany | €9.87 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Mingyue Optical Lens Co.Ltd.
SHE:301101
|
China | CN¥2.09 Billion |
|
Shanghai Kindly Entrp Dvlp Grp
SHG:603987
|
China | CN¥4.24 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$7.44 Billion |
|
AVE Science & Technology Co Ltd
SHG:688067
|
China | CN¥611.46 Million |
|
Medeon Biodesign
TWO:6499
|
Taiwan | NT$1.55 Billion |
|
Nextgen
TA:NXGN
|
Israel | ILA1.48 Million |
RENAU.UNSP.ARD 1/5 EO-20 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.16 | 1.91 | 2.14 |
| Quick Ratio | 0.55 | 1.18 | 1.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €186.20 Million | €861.00 Million | €862.60 Million |
RENAU.UNSP.ARD 1/5 EO-20 - Advanced Valuation Insights
This section examines the relationship between RENAU.UNSP.ARD 1/5 EO-20's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.97 |
| Latest Market Cap to Assets Ratio | 2.13 |
| Asset Growth Rate (YoY) | -3.3% |
| Total Assets | €7.98 Billion |
| Market Capitalization | $17.02 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values RENAU.UNSP.ARD 1/5 EO-20's assets at a significant premium (2.13x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: RENAU.UNSP.ARD 1/5 EO-20's assets decreased by 3.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for RENAU.UNSP.ARD 1/5 EO-20 (2022–2025)
The table below shows the annual total assets of RENAU.UNSP.ARD 1/5 EO-20 from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €7.98 Billion ≈ $9.33 Billion |
-3.30% |
| 2024-12-31 | €8.26 Billion ≈ $9.65 Billion |
+6.81% |
| 2023-12-31 | €7.73 Billion ≈ $9.04 Billion |
+52.61% |
| 2022-12-31 | €5.07 Billion ≈ $5.92 Billion |
-- |
About RENAU.UNSP.ARD 1/5 EO-20
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more